Detail

Keywords

Anti-Bacterial Agents; Biomarkers, Pharmacological; Clinical Trial, Phase I; Drug Monitoring; Microdialysis; Tissue Distribution

Selected publications

1. Sanz-Codina, M. et al. (2023) ‘Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials’, Clinical Microbiology and Infection, 29(7), pp. 845–857. Available at: https://doi.org/10.1016/j.cmi.2023.03.018. Available at: http://dx.doi.org/.
2. Sanz Codina, M. and Zeitlinger, M. (2022) ‘Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review’, Clinical Pharmacokinetics, 61(5), pp. 593–617. Available at: https://doi.org/10.1007/s40262-021-01102-1. Available at: http://dx.doi.org/.
3. Sanz Codina, M. et al. (2022) ‘Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem’, Pharmaceutics, 14(8), p. 1585. Available at: https://doi.org/10.3390/pharmaceutics14081585. Available at: http://dx.doi.org/.
4. Sanz-Codina, M. et al. (2022) ‘Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determination’, Journal of Antimicrobial Chemotherapy, 78(2), pp. 380–388. Available at: https://doi.org/10.1093/jac/dkac400. Available at: http://dx.doi.org/.